Incretin Signalling Research: GLP-1, GIP, and Metabolic Regulation
Incretin signalling research examines how gastrointestinal hormones connect nutrient intake with pancreatic and metabolic responses. Two hormones dominate this field: glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP). Both hormones contribute to glucose-dependent insulin regulation. However, they activate different receptors and differ in glucagon signalling and broader metabolic activity. These distinctions have become particularly important […]
Retatrutide Mechanism of Action: GLP-1, GIP, and Glucagon Receptor Signalling
The retatrutide mechanism of action centres on simultaneous activity at three metabolically important receptors: glucose-dependent insulinotropic polypeptide (GIP), glucagon-like peptide-1 (GLP-1), and glucagon receptors. Retatrutide, also known as LY3437943, is a single engineered peptide rather than a mixture of three separate receptor agonists. For researchers exploring metabolic compounds through Pure Peptides, this triple-receptor design provides […]